Annual Total Expenses
$234.88 M
+$67.25 M+40.12%
December 31, 2023
Summary
- As of February 7, 2025, VERV annual total expenses is $234.88 million, with the most recent change of +$67.25 million (+40.12%) on December 31, 2023.
- During the last 3 years, VERV annual total expenses has risen by +$194.25 million (+478.14%).
- VERV annual total expenses is now at all-time high.
Performance
VERV Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$63.77 M
-$1.76 M-2.68%
September 30, 2024
Summary
- As of February 7, 2025, VERV quarterly total expenses is $63.77 million, with the most recent change of -$1.76 million (-2.68%) on September 30, 2024.
- Over the past year, VERV quarterly total expenses has increased by +$8.32 million (+15.01%).
- VERV quarterly total expenses is now -2.68% below its all-time high of $65.53 million, reached on June 30, 2024.
Performance
VERV Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
VERV Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +40.1% | +15.0% |
3 y3 years | +478.1% | +15.0% |
5 y5 years | +1621.8% | +15.0% |
VERV Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +169.8% | -2.7% | +99.8% |
5 y | 5-year | at high | +1621.8% | -2.7% | +853.9% |
alltime | all time | at high | +1621.8% | -2.7% | +853.9% |
Verve Therapeutics Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $63.77 M(-2.7%) |
Jun 2024 | - | $65.53 M(+4.8%) |
Mar 2024 | - | $62.54 M(+5.8%) |
Dec 2023 | $234.88 M(+40.1%) | $59.09 M(+6.6%) |
Sep 2023 | - | $55.45 M(-8.6%) |
Jun 2023 | - | $60.68 M(+1.7%) |
Mar 2023 | - | $59.66 M(+22.5%) |
Dec 2022 | $167.63 M | $48.72 M(+8.8%) |
Sep 2022 | - | $44.79 M(+6.2%) |
Jun 2022 | - | $42.19 M(+32.2%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $31.93 M(-1.9%) |
Dec 2021 | $87.07 M(+114.3%) | $32.54 M(+38.5%) |
Sep 2021 | - | $23.50 M(+38.5%) |
Jun 2021 | - | $16.96 M(+20.6%) |
Mar 2021 | - | $14.06 M(-20.1%) |
Dec 2020 | $40.63 M(+197.8%) | - |
Dec 2020 | - | $17.60 M(+96.2%) |
Sep 2020 | - | $8.97 M(+34.2%) |
Jun 2020 | - | $6.69 M(-9.3%) |
Mar 2020 | - | $7.37 M |
Dec 2019 | $13.64 M | - |
FAQ
- What is Verve Therapeutics annual total expenses?
- What is the all time high annual total expenses for Verve Therapeutics?
- What is Verve Therapeutics annual total expenses year-on-year change?
- What is Verve Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Verve Therapeutics?
- What is Verve Therapeutics quarterly total expenses year-on-year change?
What is Verve Therapeutics annual total expenses?
The current annual total expenses of VERV is $234.88 M
What is the all time high annual total expenses for Verve Therapeutics?
Verve Therapeutics all-time high annual total expenses is $234.88 M
What is Verve Therapeutics annual total expenses year-on-year change?
Over the past year, VERV annual total expenses has changed by +$67.25 M (+40.12%)
What is Verve Therapeutics quarterly total expenses?
The current quarterly total expenses of VERV is $63.77 M
What is the all time high quarterly total expenses for Verve Therapeutics?
Verve Therapeutics all-time high quarterly total expenses is $65.53 M
What is Verve Therapeutics quarterly total expenses year-on-year change?
Over the past year, VERV quarterly total expenses has changed by +$8.32 M (+15.01%)